Internal Medicine, Pulmonary Disease · New York, NY
NPI
1356314017
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
305 2nd Ave, Suite 16
New York, NY, 10003
Phone (212) 598-6516
Groups this clinician bills Medicare through
Medicare paid, 2024
$100K
2,039 services
Medicare patients, 2024
231
Average age 76
Drug cost, 2024
$247K
411 prescriptions
Company payments, 2025
$14K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Doreen Addrizzo-Harris was code J7613 (albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg), 500 times for 136 patients. In total Doreen Addrizzo-Harris billed 2,039 services in 26 codes, and Medicare paid $100K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-08.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 500 | 136 | $0.04 | $20.45 |
| 99214 Office E&M - Established | Office | 262 | 159 | $109.73 | $29K |
| 99215 Office E&M - Established | Office | 194 | 107 | $154.85 | $30K |
| 36415 Venipuncture Blood Collection | Office | 191 | 114 | $8.65 | $1,652 |
| 94060 Pulmonary Function Testing | Office | 186 | 146 | $34.48 | $6,414 |
| 94729 Pulmonary Function Testing | Office | 166 | 141 | $50.89 | $8,447 |
| 94726 Pulmonary Function Testing | Office | 165 | 141 | $49.98 | $8,247 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 120 | 85 | $14.35 | $1,722 |
| 99213 Office E&M - Established | Office | 73 | 62 | $78.82 | $5,754 |
| 93000 Electrocardiogram | Office | 64 | 33 | $12.92 | $827 |
| 94618 Pulmonary Function Testing | Office | 37 | 26 | $30.14 | $1,115 |
| 99205 Office E&M - New | Office | 29 | 29 | $184.41 | $5,348 |
| 94010 Pulmonary Function Testing | Office | 15 | 12 | $24.80 | $372 |
| J7612 Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg | Office | 13 | 11 | $0.20 | $2.64 |
By year: 2022 $86K for 1,145 services; 2023 $78K for 1,526 services; 2024 $100K for 2,039 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 191 | 114 | $8.65 | $1,652 |
Medicare prescription drug claims, 2024
In 2024, the drug Doreen Addrizzo-Harris prescribed most often to Medicare patients was Imipenem-Cilastatin Sodium (Imipenem/Cilastatin Sodium), with 38 prescriptions and refills. In total Doreen Addrizzo-Harris wrote 411 Medicare prescriptions that cost $247K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imipenem-Cilastatin Sodium Imipenem/Cilastatin Sodium | 38 | 38 | Under 11 | $24K |
| Avycaz Ceftazidime/Avibactam | 31 | 31 | Under 11 | $141K |
| Amikacin Sulfate Generic | 28 | 28 | Under 11 | $1,513 |
| Ceftazidime Generic | 28 | 28 | Under 11 | $4,211 |
| Ethambutol Hcl Generic | 26 | 30 | Under 11 | $787 |
| Prednisone Generic | 21 | 23 | Under 11 | $65.16 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 18 | 20 | Under 11 | $372 |
| Azithromycin Generic | 18 | 23 | Under 11 | $208 |
| Tigecycline Generic | 16 | 16 | Under 11 | $9,583 |
| Cefepime Hcl Generic | 16 | 16 | Under 11 | $2,875 |
| Aztreonam Generic | 13 | 13 | Under 11 | $17K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 13 | 13 | Under 11 | $6,081 |
| Spiriva Handihaler Tiotropium Bromide | 13 | 15 | Under 11 | $8,107 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 11 | 11 | Under 11 | $65.92 |
| Famotidine Generic | 11 | 15 | Under 11 | $77.16 |
Brand drugs: 102 claims; generic drugs: 309 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Doreen Addrizzo-Harris $14K ($14K in general payments such as food, travel and fees) from 7 companies. The largest payer was Paratek Pharmaceuticals, Inc. with $12K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.